Back to news

Representative Eugene Vindman introduces H.R. 10970: Cardiovascular Disease Early Detection and Prevention Act of 2026

Investivoq LegislationRadar

We have received text from H.R. 10970: Cardiovascular Disease Early Detection and Prevention Act of 2026. This bill was received on 2026-11-09, and currently has no cosponsors.

Here is a short summary of the bill:

This bill would require health coverage to pay for two blood tests— lipoprotein(a) and apolipoprotein B (ApoB) —for certain people who are at higher risk of cardiovascular disease, without charging them a copay, deductible, or other cost-sharing amount.

What tests would be covered

The bill specifically adds coverage for testing of:

  • Lipoprotein(a), or Lp(a)
  • Apolipoprotein B, or ApoB

These tests would be covered for people with certain risk factors, including:

  • a family history of early cardiovascular disease;
  • a prior heart attack;
  • a prior stroke;
  • elevated LDL cholesterol;
  • diabetes;
  • obesity; or
  • other recognized cardiovascular risk factors.

Who would be affected

The coverage requirement would apply to:

  • Group health plans and individual and group health insurance plans regulated under federal law;
  • Medicare ;
  • Medicaid , including certain Medicaid benchmark and benchmark-equivalent plans.

What the bill changes for patients

For people who meet the risk criteria, the tests would have to be provided without cost sharing . That means the patient would not have to pay part of the bill themselves for these screenings under the covered programs and plans.

Timing

The private insurance changes would take effect for plan years beginning 180 days after enactment . The Medicare and Medicaid changes would apply to covered services provided on or after that same date.

Purpose stated in the bill

The bill says the goal is earlier detection and prevention of cardiovascular disease. Its findings note that routine cholesterol panels may miss elevated Lp(a) and ApoB levels, and that these markers can help identify cardiovascular risk.

Relevant Companies

  • ELV — Health insurer with Medicare and Medicaid plans that could need to cover these tests without cost sharing where applicable.
  • UNH — Health insurer that could be affected by required coverage in commercial and government-sponsored plans.
  • HUM — Health insurer with Medicare-related business that could be affected by the new coverage rules.
  • CVS — Through its health insurance and managed care operations, it could be affected by the mandated coverage requirements.
  • CNC — Medicaid-focused managed care company that could be affected by required Medicaid coverage of the tests.

Representative Eugene Vindman Bill Proposals

Here are some bills which have recently been proposed by Representative Eugene Vindman:

  • H.R.10989: To amend the Federal Power Act to provide that activities to maintain or increase the capacity of the electric grid within certain areas are a category of actions designated as being categorically excluded from the preparation of an environmental assessment or an environmental impact statement under the National Environmental Policy Act of 1969, and for other purposes.
  • H.R.10988: To amend the Federal Power Act to direct the Federal Energy Regulatory Commission to require that public utilities use advanced transmission technologies when carrying out certain projects, and for other purposes.
  • H.R.10987: To require the Federal Energy Regulatory Commission to establish procedures by which 1 or more States may refer a public utility for an investigation, and for other purposes.
  • H.R.10970: Cardiovascular Disease Early Detection and Prevention Act of 2026
  • H.R.10950: Data Center Oversight Act
  • H.R.10905: No Personal Data in Grocery Pricing Act

You can track bills proposed by Representative Eugene Vindman on Investivoq's politician page for Vindman.

Representative Eugene Vindman Net Worth

Investivoq estimates that Representative Eugene Vindman is worth $1.2M, as of November 11th, 2026. This is the 321st highest net worth in Congress, per our live estimates.

Vindman has approximately $362.3K invested in publicly traded assets which Investivoq is able to track live.

You can track Representative Eugene Vindman's net worth on Investivoq's politician page for Vindman.

2026 Virginia's 7th Congressional District Election

There has been approximately $24,839,790 of spending in Virginia's 7th congressional district elections over the last two years, per our estimates.

Approximately $738,435 of this has been from outside spending by PACs and Super PACs. Some of the groups who are spending money in this race include:

  • VOTEVETS ($270,000)
  • AMERICAN MAJORITY ACTION PAC ($211,590)
  • THE CONSERVATIVE CAUCUS DBA AMERICANS FOR CONSTITUTIONAL LIBERTY ($83,538)
  • HMP ($67,339)
  • AB PAC ($59,555)

The rating for this race is currently "Likely D".

You can track this election on our matchup page for the 2026 Virginia's 7th congressional district election.

This article is not financial advice. See Investivoq's disclaimers for more information.